Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$50 Mln
Revenue (TTM)
$233 Mln
Net Profit (TTM)
$0 Mln
ROE
-3.3 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
1.6
Industry P/E
--
EV/EBITDA
-7.7
Div. Yield
0 %
Debt to Equity
-33.1
Book Value
$--
EPS
$-1.9
Face value
--
Shares outstanding
55,054,268
CFO
$-191.51 Mln
EBITDA
$-325.17 Mln
Net Profit
$-993.70 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Cardlytics (CDLX)
| -1.7 | 30.8 | -1.7 | -40.2 | -30.7 | -60.6 | -- |
|
BSE Sensex
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Cardlytics (CDLX)
| -69.0 | -59.4 | 59.3 | -91.3 | -53.7 | 127.1 | 480.4 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Cardlytics (CDLX)
|
1.1 | 49.5 | 233.3 | -103.5 | -39.9 | -326 | -- | 1.6 |
| 21.8 | 360.1 | 3,542.6 | -227.7 | -3.6 | -35 | -- | 0.4 | |
| 17.4 | 2,030.4 | 6,276.3 | 1,403.5 | 11.5 | 6 | 10.1 | 0.6 | |
| 2.4 | 1,186.4 | 1,604.1 | -104.7 | 16.7 | 3 | -- | 0.0 | |
| 18.5 | 893.1 | 1,944.9 | 144.6 | 10.6 | 13.2 | 6.6 | 0.8 | |
| 11.9 | 1,670.3 | 714.0 | 144.6 | 14.3 | 17.1 | 12.2 | 1.9 | |
| 25.4 | 783.4 | 1,380.6 | 22.6 | 12.0 | 4.3 | 35.5 | 1.4 | |
| 6.3 | 1,576.5 | 2,909.0 | 29.1 | 5.4 | 5.3 | 77.8 | 2.0 | |
| 33.9 | 3,084.8 | 1,007.9 | 169.5 | 14.4 | 7.4 | 15.1 | 1.3 | |
| 5.7 | 84.0 | 427.4 | -11.5 | 10.5 | 30.2 | -- | 29.2 |
Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. The company provides Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through digital channels,... such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data from merchant data partners, including product-level purchase data to enable marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. Cardlytics, Inc. was incorporated in 2008 and is headquartered in Atlanta, Georgia. Address: 675 Ponce de Leon Avenue NE, Atlanta, GA, United States, 30308 Read more
CEO & Director
Mr. Karim Temsamani
Chief Financial Officer
Ms. Alexis DeSieno
Headquarters
Atlanta, GA
Website
The share price of Cardlytics Inc (CDLX) is $1.13 (NASDAQ) as of 02-Apr-2026 19:59 EDT. Cardlytics Inc (CDLX) has given a return of -30.7% in the last 3 years.
Since, TTM earnings of Cardlytics Inc (CDLX) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-0.59
|
-9.39
|
|
2024
|
-1.00
|
2.70
|
|
2023
|
-2.70
|
2.70
|
|
2022
|
-0.42
|
0.91
|
|
2021
|
-17.17
|
3.20
|
The 52-week high and low of Cardlytics Inc (CDLX) are Rs 3.28 and Rs 0.66 as of 04-Apr-2026.
Cardlytics Inc (CDLX) has a market capitalisation of $ 50 Mln as on 31-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Cardlytics Inc (CDLX), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.